Abiopharma

🔍 Kaplan Andrew Jay (Director)

Company: NextTrip, Inc. (NTRP)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 18,182 shares of Common stock at $2.75 per share (Direct)
  Date: 2026-05-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 51,582.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common stock (Direct)
  Date: 2026-05-08 | Code: H | nature_of_ownership: By Kaplan Wright Family Trust | shares_owned_after: 36,250.00 | Footnotes: F2
• Acquired 9,091 shares of Warrants to purchase common stock at $3.0 per share (Derivative)
  Date: 2026-05-08 | Code: J | Expires: 2029-05-08 | Exercise: 2026-05-08 | equity_swap_involved: 0 | shares_owned_after: 129,124.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The Issuer and KC Global Media Asia, LLC ("KCGM") entered into a Securities Purchase Agreement on May 8, 2026 pursuant to which KCGM purchased from Issuer in a private transaction 18,182 shares of common stock and warrants to purchase 9,091 shares of common stock for a purchase price of $50,000.
• F2: Mr. Kaplan disclaims beneficial ownership of all securities held by KCGM and the Kaplan Wright Family Trust (the "Trust") in excess of his pecuniary interest, if any, and this report shall not be deemed an admission that he is the beneficial owner of, or has pecuniary interest in, any such excess shares for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• F3: The securities are held by KCGM. Mr. Kaplan serves as Chairman of KCGM and is deemed to beneficially own the securities held by KCGM.
• F4: The shares are held by the Trust. Mr. Kaplan is the trustee of the Trust. As such, Mr. Kaplan is deemed to beneficially own the securities held by the Trust.